The forgotten class of drugs for multiple myeloma: HDAC inhibitors

Lancet Haematol. 2018 Dec;5(12):e604-e605. doi: 10.1016/S2352-3026(18)30194-7.
No abstract available

MeSH terms

  • Histone Deacetylase Inhibitors / therapeutic use*
  • Humans
  • Multiple Myeloma / drug therapy*
  • Treatment Outcome

Substances

  • Histone Deacetylase Inhibitors